FDAnews Device Daily Bulletin
March 7, 2005 | Vol. 2 No. 46
Johnson & Johnson (J&J) has reached a deal to buy Closure Medical, a maker of wound adhesives, for roughly $370 million in cash.
Eastman Kodak has announced the completion of its acquisition of OREX Computed Radiography, a provider of compact, robust computed radiography systems that enable medical practitioners to acquire patient X-ray images digitally.
Triage Medical has received FDA marketing clearance for its BONE-LOK Products for spinal fixation -- including degenerative disc disease, trauma and failed previous fusion.
LifeSpan Biosciences has entered into an agreement with Pfizer to develop an automated pathology system for rapid and accurate evaluation of tissue specimens in preclinical studies.
Smiths Medical has announced the expansion of their
epidural tray product line to include needle protection safety devices, providing
anesthesiologists and infection control customers with increased product flexibility
and the only complete line of epidural trays available from one source.
NIR Diagnostics, a developer of near-infrared handheld reagentless medical instruments, announced that it has successfully concluded a supply agreement with Boehringer Ingelheim microParts based in Germany.
Biocompatibles International, the medical device company focused on the treatment of cancer and cardiovascular disease, has conditionally agreed to acquire Germany's CellMed for up to €22.2 million in cash and shares.
Ambion Diagnostics announced the adoption of its first molecular genetic test, Signature CF 2.0 ASR, by The Blood Center of Southeastern Wisconsin.
Beckman Coulter began shipping its new Cell Lab IC 100 image cytometer.
Genpathway announced the availability of its novel tools enabling discovery and characterization of differential gene transcription, components and processes for gene regulation and corresponding genetic pathways.
Ophthonix, a vision care company developing a "high-definition" vision technology that provides consumers with superior optical clarity and crispness compared to any other available vision corrections, has hired Thomas George as chief financial officer (CFO) to oversee all financial controls, organization and relationships.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.